Indication
Adverse Reaction
6 clinical trials
7 products
1 drug
Clinical trial
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial on DH001 Tablets in the Prevention of Doxorubicin-induced Cardiotoxicity in Cancer PatientsStatus: Recruiting, Estimated PCD: 2025-01-31
Product
DH001Clinical trial
The Efficacy and Tolerability of Acarbose in Healthy Individuals: A Prospective Trial for Acarbose in Healthy Individuals Assessing Safety and Efficacy in Reducing Glucose Spikes After Carbohydrate Consumption.Status: Completed, Estimated PCD: 2022-10-05
Product
AcarboseClinical trial
Clinical Relevance of Nicardipine Induced Hypoxemia in the Intensive Care Unit. A Multicenter Prospective Observational Study Comparing Nicardipine and UrapidilStatus: Active (not recruiting), Estimated PCD: 2023-11-15
Product
Antihypertensive AgentsClinical trial
Risk Analysis of Cardiotoxic Medication Use Due to Sodium Arsenite Chloride InjectionStatus: Recruiting, Estimated PCD: 2023-12-31
Product
Sodium arsenite chlorideClinical trial
Open-label, Multicenter, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Aripiprazole vs Paliperidone/Risperidone Using Multi-omics Data in Patients With a First Episode PsychosisStatus: Not yet recruiting, Estimated PCD: 2025-06-01
Product
AripiprazoleProduct
PaliperidoneClinical trial
Colchicine for Prevention Atrial Fibrillation After Cardiac Surgery in the Early Postoperative PeriodStatus: Completed, Estimated PCD: 2022-08-15
Product
ColchicineDrug
Varlilumab